GB Patent

GB2122087A — Topical corticosteroid preparation

Assigned to Shionogi and Co Ltd · Expires 1984-01-11 · 42y expired

What this patent protects

Anti-inflammatory preparations comprise a monoglyceride of a C6-C10 fatty acid and a corticosteroid. The steroid may be betamethasone, alclometasone, hydrocortisone, prednisolone, triamcinolone, fluocinonide, fluocinolone, dexamethasone, diflucostolone or beclometasone; the monog…

USPTO Abstract

Anti-inflammatory preparations comprise a monoglyceride of a C6-C10 fatty acid and a corticosteroid. The steroid may be betamethasone, alclometasone, hydrocortisone, prednisolone, triamcinolone, fluocinonide, fluocinolone, dexamethasone, diflucostolone or beclometasone; the monoglyceride of a monoglyceride can be glycerol monohexanoate, monooctanoate or monodecanoate.

Drugs covered by this patent

Patent Metadata

Patent number: GB2122087A
Jurisdiction: GB
Classification: —
Expires: 1984-01-11
Drug substance claim: No
Drug product claim: No
Assignee: Shionogi and Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.